A detailed history of Diversified Trust CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Diversified Trust CO holds 12,639 shares of EXAS stock, worth $708,163. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,639
Previous 11,931 5.93%
Holding current value
$708,163
Previous $812,000 12.56%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 07, 2025

BUY
$49.33 - $71.97 $34,925 - $50,954
708 Added 5.93%
12,639 $710,000
Q3 2024

Oct 07, 2024

BUY
$42.43 - $70.83 $67,633 - $112,903
1,594 Added 15.42%
11,931 $812,000
Q2 2024

Jul 16, 2024

BUY
$41.33 - $74.26 $14,754 - $26,510
357 Added 3.58%
10,337 $436,000
Q1 2024

Apr 18, 2024

BUY
$56.27 - $73.77 $325,578 - $426,833
5,786 Added 137.96%
9,980 $689,000
Q4 2023

Jan 08, 2024

BUY
$59.06 - $75.72 $247,697 - $317,569
4,194 New
4,194 $310,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.92B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.